EXHIBIT 10(sss) SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this "Agreement") is dated as of April 30, 2017, between CEL-SCI Corporation, a Colorado corporation (the "Company"), and each purchaser identified on the signature...Securities Purchase Agreement • May 2nd, 2017 • Cel Sci Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 2nd, 2017 Company Industry Jurisdiction
EXHIBIT 4(q) NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION...Securities Agreement • May 2nd, 2017 • Cel Sci Corp • Biological products, (no disgnostic substances)
Contract Type FiledMay 2nd, 2017 Company Industry
EXHIBIT 4(r) NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION...Security Agreement • May 2nd, 2017 • Cel Sci Corp • Biological products, (no disgnostic substances)
Contract Type FiledMay 2nd, 2017 Company Industry
April 30, 2017 STRICTLY CONFIDENTIAL CEL-SCI Corporation 8229 Boone Blvd., Suite 802 Vienna, Virginia 22182 Attn: Geert R. Kersten, Chief Executive Officer Dear Mr. Kersten: This letter agreement (this "Agreement") constitutes the agreement between...Exclusive Agency Agreement • May 2nd, 2017 • Cel Sci Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 2nd, 2017 Company Industry Jurisdiction